午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

ChemicalBook >> journal list >> Journal of Advances in Medicine and Medical Research >>article

Evaluation of Intralesional Injection of 5-fluorouracil in Treatment of Vitiligo

Published:19 March 2021 DOI: 10.9734/JAMMR/2021/V33I630856
D. M. Anber,?D. M. Ali,?R. El-Tatawy,?L. Elgarhy

Abstract

Background: Vitiligo is a chronic cutaneous disease characterized by depigmented patches that leave psychological impact on the patients. New treatment modalities have been developed to improve the results vitiligo with less side effects. Objective: To evaluate intralesional injection of 5-fluorouracil in treatment of vitiligo. Patients and Methods: The study included 20 localized stable vitiligo patients. Each patient was treated with intralesional injection of 5-fluorouracil every 2 weeks for 3 sessions followed by narrow band sessions twice weekly for 3 months. Results: There was statistically significant repigmentation after treatment with intralesional 5-FU (mean of 50.30 ± 34.60, P value =0.001 Wilcoxon signed ranks test between before and after). 55% of patients showed >50% repigmentation. after 3 months therapy. Side effects were minimal and transient. Conclusion: Intralesional injection of 5-FU is safe and effective in the treatment of vitiligo.

Substances (2)

Related products
Procduct Name CAS Molecular Formula Supplier Price
5-Fluorouracil 51-21-8 C4H3FN2O2 949 suppliers $5.00-$2492.67
5-Fluorouridine 77180-80-4 C9H11FN2O6 118 suppliers Inquiry

Similar articles

IF:0

Triamcinolone Acetonide and 5-Fluorouracil Intralesional Combination Injection in Keloid Treatment

International Journal of Integrated Health Sciences Jono Hadi Agusni,?Eva Krishna Sutedja,etc Published: 31 March 2017
IF:72.5

5-Fluorouracil: mechanisms of action and clinical strategies

Nature Reviews Cancer Daniel B. Longley, D. Paul Harkin,etc Published: 1 May 2003
IF:3

Safety evaluation of trabectedin in treatment of soft-tissue sarcomas.

Expert Opinion on Drug Safety Juan Martin-Liberal, Ian Judson,etc Published: 1 November 2013